Justin J. McAnear - 01 Jun 2021 Form 4 Insider Report for 10x Genomics, Inc. (TXG)

Role: Chief Financial Officer
Signature: /s/ Eric S. Whitaker, as Attorney-in-Fact
Issuer symbol: TXG
Transactions as of: 01 Jun 2021
Net transactions value: -$1,693,669
Form type: 4
Filing time: 03 Jun 2021, 18:51:14 UTC
Previous filing: 26 May 2021
Next filing: 06 Jul 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	TXG	Class A Common Stock	Options Exercise	$50,400	+10,000	+26%	$5.04^*	49,011	01 Jun 2021	Direct	F1
transaction	TXG	Class A Common Stock	Sale	$428,984	-2,500	-5.1%	$171.59	46,511	01 Jun 2021	Direct	F1, F2
transaction	TXG	Class A Common Stock	Sale	$138,279	-800	-1.7%	$172.85	45,711	01 Jun 2021	Direct	F1, F3
transaction	TXG	Class A Common Stock	Sale	$173,944	-1,000	-2.2%	$173.94	44,711	01 Jun 2021	Direct	F1, F4
transaction	TXG	Class A Common Stock	Sale	$348,808	-1,994	-4.5%	$174.93	42,717	01 Jun 2021	Direct	F1, F5
transaction	TXG	Class A Common Stock	Sale	$510,786	-2,906	-6.8%	$175.77	39,811	01 Jun 2021	Direct	F1, F6
transaction	TXG	Class A Common Stock	Sale	$53,420	-300	-0.75%	$178.07	39,511	01 Jun 2021	Direct	F1, F7
transaction	TXG	Class A Common Stock	Sale	$35,842	-200	-0.51%	$179.21	39,311	01 Jun 2021	Direct	F1, F8
transaction	TXG	Class A Common Stock	Sale	$54,007	-300	-0.76%	$180.02	39,011	01 Jun 2021	Direct	F1, F9

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	TXG	Stock Option (right to buy)	Options Exercise	$0	-10,000	-2.3%	$0.000000	420,159	01 Jun 2021	Class A Common Stock	10,000	$5.04	Direct	F1, F10

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This option exercise and the sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person.
F2	This transaction was executed in multiple trades at prices ranging from $171.12 to $172.02. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F3	This transaction was executed in multiple trades at prices ranging from $172.25 to $173.14. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F4	This transaction was executed in multiple trades at prices ranging from $173.36 to $174.31. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F5	This transaction was executed in multiple trades at prices ranging from $174.38 to $175.37. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F6	This transaction was executed in multiple trades at prices ranging from $175.42 to $176.40. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F7	This transaction was executed in multiple trades at prices ranging from $177.65 to $178.60. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F8	This transaction was executed in multiple trades at prices ranging from $178.92 to $179.39. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F9	This transaction was executed in multiple trades at prices ranging from $179.97 to $180.10. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F10	This option, originally for 600,000 shares, of which 179,841 shares have been exercised, vested as to one-fourth of the shares on October 8, 2019 and one forty-eighth of the shares subject to the option vest each month thereafter, subject to the Reporting Person continuing as a service provider through each such date.